Vera Therapeutics VERA
NASDAQ VERA
$30.42 -0.57 (-1.84%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vera Therapeutics (VERA) Selling, General & Administrative (2020 - 2026)

Updated

Vera Therapeutics (VERA) recorded Selling, General & Administrative of $52.41 million in Q2 2026, up 138.8% from $21.95 million a year earlier and up 34.0% from the prior quarter.

Analysis

Vera Therapeutics (VERA) Selling, General & Administrative (2020 - 2026) Analysis & Trends

On a TTM basis, Vera Therapeutics' Selling, General & Administrative came in at $153.89 million as of Jun 30, 2026, up 144.6% year-over-year; for FY2025, it was $100.22 million, up 144.4% from FY2024.

  • Annual Selling, General & Administrative has increased for five straight years, with a five-year compound annual growth rate of 90.1% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $41 million in FY2024 (+72.4%), $23.79 million in FY2023 (+8.6%), $21.91 million in FY2022 (+83.8%) and $11.92 million in FY2021 (+195.1%).
  • The Q2 2026 figure is the highest quarterly Selling, General & Administrative in data going back to Q1 2020.
  • On a year-over-year basis, Selling, General & Administrative has increased for ten consecutive quarters, with growth averaging 136.2% over the last eight quarters.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 465.6% in Q3 2021, against a decline of 9.6% in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $39.12 million (Q1 2026), $34.9 million (Q4 2025) and $27.46 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Vera Therapeutics 2.23 Bn 2.23 Bn - 52.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52.41 Mn
Mar 31, 2026 39.12 Mn
Dec 31, 2025 34.90 Mn
Sep 30, 2025 27.46 Mn
Jun 30, 2025 21.95 Mn
Mar 31, 2025 15.92 Mn
Dec 31, 2024 15.57 Mn
Sep 30, 2024 9.49 Mn
Jun 30, 2024 8.03 Mn
Mar 31, 2024 7.91 Mn
Dec 31, 2023 6.24 Mn
Sep 30, 2023 5.66 Mn
Jun 30, 2023 5.74 Mn
Mar 31, 2023 6.15 Mn
Dec 31, 2022 6.91 Mn
Sep 30, 2022 5.59 Mn
Jun 30, 2022 4.95 Mn
Mar 31, 2022 4.47 Mn
Dec 31, 2021 3.83 Mn
Sep 30, 2021 3.69 Mn
API Access

Vera Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VERA&period=max&api_key=YOUR_API_KEY